{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T17:34:52Z","timestamp":1791221692577,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T00:00:00Z","timestamp":1748563200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["T32CA275777"],"award-info":[{"award-number":["T32CA275777"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["DA043507"],"award-info":[{"award-number":["DA043507"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["DA038000"],"award-info":[{"award-number":["DA038000"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["S10OD034326"],"award-info":[{"award-number":["S10OD034326"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007623","name":"School of Medicine, Emory University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007623","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Pharmaceutica Sinica B"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.apsb.2025.05.041","type":"journal-article","created":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T02:52:10Z","timestamp":1748919130000},"page":"6714-6726","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Development of a novel 18F-labeled reversible-binding radioligand for imaging monoacylglycerol lipase with positron emission tomography"],"prefix":"10.1016","volume":"15","author":[{"given":"Jian","family":"Rong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0168-2130","authenticated-orcid":false,"given":"Chunyu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-0614-3335","authenticated-orcid":false,"given":"Ahmad F.","family":"Chaudhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Ware","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard S.","family":"Van","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8864-1712","authenticated-orcid":false,"given":"Yinlong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erick R.","family":"Calderon Leon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivi","family":"Dang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwei","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyang","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimmy S.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9337-341X","authenticated-orcid":false,"given":"Yihan","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chongzhao","family":"Ran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludovic","family":"Collin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Achi","family":"Haider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin F.","family":"Cravatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1413-6315","authenticated-orcid":false,"given":"Steven H.","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.apsb.2025.05.041_bib1","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.chembiol.2007.11.006","article-title":"A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol","volume":"14","author":"Blankman","year":"2007","journal-title":"Chem Biol"},{"key":"10.1016\/j.apsb.2025.05.041_bib2","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1021\/cr0782067","article-title":"Enzymatic pathways that regulate endocannabinoid signaling in the nervous system","volume":"108","author":"Ahn","year":"2008","journal-title":"Chem Rev"},{"key":"10.1016\/j.apsb.2025.05.041_bib3","doi-asserted-by":"crossref","first-page":"6859","DOI":"10.1039\/C4CS00047A","article-title":"Chemical approaches to therapeutically target the metabolism and signaling of the endocannabinoid 2-AG and eicosanoids","volume":"43","author":"Kohnz","year":"2014","journal-title":"Chem Soc Rev"},{"key":"10.1016\/j.apsb.2025.05.041_bib4","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1021\/acs.jmedchem.6b00538","article-title":"Therapeutic potential of fatty acid amide hydrolase, monoacylglycerol lipase, and N-acylethanolamine acid amidase inhibitors","volume":"60","author":"Tuo","year":"2017","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2025.05.041_bib5","first-page":"809","article-title":"Endocannabinoid hydrolysis generates brain prostaglandins that promote neuroinflammation","volume":"334","author":"Nomura","year":"2011","journal-title":"Sci Technol Humanit"},{"key":"10.1016\/j.apsb.2025.05.041_bib6","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1111\/j.1476-5381.2012.01950.x","article-title":"Monoacylglycerol lipase\u2015a target for drug development?","volume":"166","author":"Fowler","year":"2012","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.apsb.2025.05.041_bib7","doi-asserted-by":"crossref","first-page":"13765","DOI":"10.1002\/anie.201407807","article-title":"A reversible and selective inhibitor of monoacylglycerol lipase ameliorates multiple sclerosis","volume":"53","author":"Hern\u00e1ndez-Torres","year":"2014","journal-title":"Angew Chem Int Ed"},{"key":"10.1016\/j.apsb.2025.05.041_bib8","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1021\/acs.jmedchem.8b00070","article-title":"Discovery of trifluoromethyl glycol carbamates as potent and selective covalent monoacylglycerol lipase (MAGL) inhibitors for treatment of neuroinflammation","volume":"61","author":"McAllister","year":"2018","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2025.05.041_bib9","doi-asserted-by":"crossref","first-page":"9062","DOI":"10.1021\/acs.jmedchem.8b00951","article-title":"Identification of ABX-1431, a selective inhibitor of monoacylglycerol lipase and clinical candidate for treatment of neurological disorders","volume":"61","author":"Cisar","year":"2018","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2025.05.041_bib10","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.bcp.2018.07.036","article-title":"Monoacylglycerol lipase (MAGL) as a promising therapeutic target","volume":"157","author":"Gil-Ord\u00f3\u00f1ez","year":"2018","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.apsb.2025.05.041_bib11","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1021\/cr0782426","article-title":"Molecular imaging with PET","volume":"108","author":"Ametamey","year":"2008","journal-title":"Chem Rev"},{"key":"10.1016\/j.apsb.2025.05.041_bib12","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1002\/anie.201805501","article-title":"Chemistry for positron emission tomography: recent advances in 11C-, 18F-, 13N-, and 15O-labeling reactions","volume":"58","author":"Deng","year":"2019","journal-title":"Angew Chem Int Ed"},{"key":"10.1016\/j.apsb.2025.05.041_bib13","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1038\/s41467-023-36377-4","article-title":"Radiochemistry for positron emission tomography","volume":"14","author":"Rong","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2025.05.041_bib14","doi-asserted-by":"crossref","first-page":"8998","DOI":"10.1002\/anie.200800222","article-title":"Synthesis of 11C, 18F, 15O, and 13N radiolabels for positron emission tomography","volume":"47","author":"Miller","year":"2008","journal-title":"Angew Chem Int Ed"},{"key":"10.1016\/j.apsb.2025.05.041_bib15","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1021\/acs.jmedchem.0c01459","article-title":"Positron emission tomography imaging of the endocannabinoid system: opportunities and challenges in radiotracer development","volume":"64","author":"Hou","year":"2021","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2025.05.041_bib16","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.7150\/thno.15257","article-title":"Synthesis and preclinical evaluation of sulfonamido-based [11C-carbonyl]-carbamates and ureas for imaging monoacylglycerol lipase","volume":"6","author":"Wang","year":"2016","journal-title":"Theranostics"},{"key":"10.1016\/j.apsb.2025.05.041_bib17","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1021\/acschemneuro.5b00293","article-title":"A novel radiotracer for imaging monoacylglycerol lipase in the brain using positron emission tomography","volume":"7","author":"Wang","year":"2016","journal-title":"ACS Chem Neurosci"},{"key":"10.1016\/j.apsb.2025.05.041_bib18","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.neuroimage.2018.05.015","article-title":"First demonstration of in vivo mapping for regional brain monoacylglycerol lipase using PET with [11C]SAR127303","volume":"176","author":"Yamasaki","year":"2018","journal-title":"Neuroimage"},{"key":"10.1016\/j.apsb.2025.05.041_bib19","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1021\/acs.jmedchem.7b01400","article-title":"In vitro and in vivo evaluation of 11C-labeled azetidinecarboxylates for imaging monoacylglycerol lipase by PET imaging studies","volume":"61","author":"Cheng","year":"2018","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2025.05.041_bib20","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ejmech.2017.04.066","article-title":"Synthesis and preclinical evaluation of [11C]MA-PB-1 for in vivo imaging of brain monoacylglycerol lipase (MAGL)","volume":"136","author":"Ahamed","year":"2017","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.apsb.2025.05.041_bib21","doi-asserted-by":"crossref","first-page":"8532","DOI":"10.1021\/acs.jmedchem.9b00847","article-title":"Identification and development of an irreversible monoacylglycerol lipase (MAGL) positron emission tomography (PET) radioligand with high specificity","volume":"62","author":"Zhang","year":"2019","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2025.05.041_bib22","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.1021\/acs.jmedchem.8b01778","article-title":"Design, synthesis, and evaluation of reversible and irreversible monoacylglycerol lipase positron emission tomography (PET) tracers using a \u201ctail switching\u201d strategy on a piperazinyl azetidine skeleton","volume":"62","author":"Chen","year":"2019","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2025.05.041_bib23","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1016\/j.apsb.2021.01.021","article-title":"Development of a highly-specific 18F-labeled irreversible positron emission tomography tracer for monoacylglycerol lipase mapping","volume":"11","author":"Chen","year":"2021","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2025.05.041_bib24","doi-asserted-by":"crossref","first-page":"8866","DOI":"10.1021\/acs.jmedchem.9b00936","article-title":"Design, synthesis, and evaluation of 18F-labeled monoacylglycerol lipase inhibitors as novel positron emission tomography probes","volume":"62","author":"Chen","year":"2019","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2025.05.041_bib25","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.nucmedbio.2022.02.002","article-title":"Discovery, synthesis and evaluation of novel reversible monoacylglycerol lipase radioligands bearing a morpholine-3-one scaffold","volume":"108\u2013109","author":"He","year":"2022","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.apsb.2025.05.041_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114750","article-title":"Multi-parameter optimization: development of a morpholin-3-one derivative with an improved kinetic profile for imaging monoacylglycerol lipase in the brain","volume":"243","author":"He","year":"2022","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.apsb.2025.05.041_bib27","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1021\/acs.jmedchem.8b01576","article-title":"Design, synthesis, and evaluation of (4R)-1-{3-[2-(18F)fluoro-4-methylpyridin-3-yl]phenyl}-4-[4-(1,3-thiazol-2-ylcarbonyl)piperazin-1-yl]pyrrolidin-2-one ([18F]t-401) as a novel positron-emission tomography imaging agent for monoacylglycerol lipase","volume":"62","author":"Hattori","year":"2019","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2025.05.041_bib28","doi-asserted-by":"crossref","first-page":"14283","DOI":"10.1021\/acs.jmedchem.1c00747","article-title":"Novel reversible-binding PET ligands for imaging monoacylglycerol lipase based on the piperazinyl azetidine scaffold","volume":"64","author":"Rong","year":"2021","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2025.05.041_bib29","doi-asserted-by":"crossref","first-page":"3002","DOI":"10.1038\/s41401-022-00912-8","article-title":"A novel monoacylglycerol lipase-targeted 18F-labeled probe for positron emission tomography imaging of brown adipose tissue in the energy network","volume":"43","author":"Cheng","year":"2022","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.apsb.2025.05.041_bib30","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1021\/acs.jmedchem.1c01706","article-title":"Development of high brain-penetrant and reversible monoacylglycerol lipase PET tracers for neuroimaging","volume":"65","author":"He","year":"2022","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2025.05.041_bib31","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.96.26.14694","article-title":"Activity-based protein profiling: the serine hydrolases","volume":"96","author":"Liu","year":"1999","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.apsb.2025.05.041_bib32","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1146\/annurev.biochem.75.101304.124125","article-title":"Activity-based protein profiling: from enzyme chemistry to proteomic chemistry","volume":"77","author":"Cravatt","year":"2008","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.apsb.2025.05.041_bib33","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/nbt826","article-title":"Discovering potent and selective reversible inhibitors of enzymes in complex proteomes","volume":"21","author":"Leung","year":"2003","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.apsb.2025.05.041_bib34","series-title":"Test No. 107: partition coefficient (n-octanol\/water): shake flask method","year":"1995"},{"key":"10.1016\/j.apsb.2025.05.041_bib35","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.mibio.2003.09.014","article-title":"Determination of lipophilicity and its use as a predictor of blood\u2012brain barrier penetration of molecular imaging agents","volume":"5","author":"Waterhouse","year":"2003","journal-title":"Mol Imag Biol"},{"key":"10.1016\/j.apsb.2025.05.041_bib36","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.nucmedbio.2008.10.002","article-title":"In vivo site-directed radiotracers: a mini-review","volume":"35","author":"Patel","year":"2008","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.apsb.2025.05.041_bib37","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.2174\/0929867323666160418114826","article-title":"Considerations in the development of reversibly binding PET radioligands for brain imaging","volume":"23","author":"Pike","year":"2016","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.apsb.2025.05.041_bib38","doi-asserted-by":"crossref","first-page":"7751","DOI":"10.1002\/anie.201404436","article-title":"A general copper-mediated nucleophilic 18F fluorination of arenes","volume":"53","author":"Tredwell","year":"2014","journal-title":"Angew Chem Int Ed"},{"key":"10.1016\/j.apsb.2025.05.041_bib39","doi-asserted-by":"crossref","first-page":"10819","DOI":"10.1073\/pnas.152334899","article-title":"Brain monoglyceride lipase participating in endocannabinoid inactivation","volume":"99","author":"Dinh","year":"2002","journal-title":"Proc Natl Acad Sci"}],"container-title":["Acta Pharmaceutica Sinica B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221138352500379X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221138352500379X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T15:02:04Z","timestamp":1771513324000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221138352500379X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":39,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S221138352500379X"],"URL":"https:\/\/doi.org\/10.1016\/j.apsb.2025.05.041","relation":{},"ISSN":["2211-3835"],"issn-type":[{"value":"2211-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of a novel 18F-labeled reversible-binding radioligand for imaging monoacylglycerol lipase with positron emission tomography","name":"articletitle","label":"Article Title"},{"value":"Acta Pharmaceutica Sinica B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apsb.2025.05.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V. on behalf of Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences.","name":"copyright","label":"Copyright"}]}}